Publicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (7)

2008

  1. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population

    Clinical Endocrinology, Vol. 68, Núm. 6, pp. 942-950

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2003

  1. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481

2002

  1. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test

    Clinical Endocrinology, Vol. 57, Núm. 3, pp. 377-384

  2. Diagnóstico del déficit de hormona del crecimiento en pacientes adultos

    Endocrinologia y Nutricion

  3. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses

    Neuroendocrinology, Vol. 76, Núm. 6, pp. 390-396

2000

  1. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

    Lancet, Vol. 356, Núm. 9236, pp. 1137-1142